Combatting Social Isolation Among Older Adults in a Time of Physical Distancing: The COVID-19 Social Connectivity ParadoxPublic Health Published on 2020-07-212022-10-31 Journal: Frontiers in Public Health [Category] Coronavirus, MERS, SARS, [키워드] aging network complex connectivity continuum COVID-19 COVID-19 pandemic Depression distanced connectivity example feasible IMPROVE Isolation loneliness maintain mitigate Older organization paradox physical distance physical distancing provide provided public health reduce resulting risk Safe Screening service provision social connectivity social isolation Social service time [DOI] 10.3389/fpubh.2020.00403 PMC 바로가기 [Article Type] Public Health
Physical Activity, Screen Time, and Emotional Well-Being during the 2019 Novel Coronavirus Outbreak in ChinaArticle Published on 2020-07-172022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, SARS, [키워드] 95% CI activity adopted Affect ANOVA China Chinese collected confirmed COVID-19 case correlation COVID-19 COVID-19 outbreak emotional evaluate the effect Health help IMPROVE individual initial less lockdown novel pandemic participant per day physical activity positive Prevalence promotion proportion psychological Impact questionnaire recall Screen screen time sedentary lifestyle Spearman’s correlation coefficient statistical analysis time were used [DOI] 10.3390/ijerph17145170 PMC 바로가기 [Article Type] Article
Tracing and analysis of 288 early SARS-CoV-2 infections outside China: A modeling studyResearch Article Published on 2020-07-172022-10-29 Journal: PLoS Medicine [Category] COVID-19, SARS, [키워드] accounted adopted Analysis analyzed Asia characterized China Chinese Cluster collected collected data Community Containment strategy contributed country COVID-19 COVID-19 case COVID-19 outbreak Critical detection rate doubling early phase East effective Epidemic Epidemics epidemiologically global pandemic growth information International Isolation Local lockdown majority management media missing novel coronavirus disease onward transmission pandemic predict predicted Prevent proportion quantified reduced reducing reported researcher responsible risk SARS-CoV-2 SARS-COV-2 infection silent South Spread statistical model the epidemic time tracing Transmission transmissions Travel virus World Health Organization [DOI] 10.1371/journal.pmed.1003193 PMC 바로가기 [Article Type] Research Article
Cancer in the Time of Coronavirus: A Call for Crisis Oncology Standards of CarePerspective Published on 2020-07-172022-10-31 Journal: International journal for equity in health [Category] COVID-19, [키워드] Academy affecting Cancer cancer patient Care coronavirus COVID-19 COVID-19 pandemic crisis defined develop Disaster preparedness global pandemic health system heterogeneous highlight Medicine oncologist oncology pandemic Patients with cancer Population proportionality recommendation resources Standard strained time variety [DOI] 10.3390/healthcare8030214 PMC 바로가기 [Article Type] Perspective
Impact of COVID-19 outbreak on regional STEMI care in GermanyObservational Study Published on 2020-07-162022-10-04 Journal: Clinical Research in Cardiology [Category] MERS, 임상, [키워드] accompanied Admission bypassing Care catheterization clinical Contact-to-balloon time coronavirus disease COVID-19 COVID-19 crisis COVID-19 outbreak decrease ECG feedback Germany hospital hospitals Impact in-hospital mortality Infarction Key quality indicators Laboratory less lockdown Logistic management Mortality Myocardial infarction pandemic Patient patients patients treated percentage Percutaneous coronary intervention (PCI) preserved proportion remained Result significant difference significantly ST-segment elevation myocardial infarction (STEMI) supplementary material the mean time transfer Transport transported treated Treatment Trial registration [DOI] 10.1007/s00392-020-01703-z PMC 바로가기 [Article Type] Observational Study
Point of Care Nucleic Acid Testing for SARS-CoV-2 in Hospitalized Patients: A Clinical Validation Trial and Implementation Study입원 환자의 SARS-CoV-2에 대한 현장 진료 핵산 검사: 임상 검증 시험 및 구현 연구Clinical Trial Published on 2020-07-152022-08-13 Journal: Cell Reports Medicine [Category] MERS, SARS, 임상, 진단, [키워드] 95% CI acid Admission avoidance Care clinical Cohen’s κ correlation COVID-19 diagnostic test discharge faster hospital implementation IMPROVE increase infection control IQR Isolation isolation rooms lab leads limit median median time mitigate NAAT nasal nosocomial nosocomial spread nucleic acid nucleic acid amplification nucleic acid amplification test nucleic acid amplification testing participant Patient care PCR testing POC POC test POC testing Point point of care positive rapid SARS-CoV-2 testing reduce RT-PCR RT-PCR testing SARS-CoV-2 swabbing Testing the median time validation [DOI] 10.1016/j.xcrm.2020.100062 PMC 바로가기 [Article Type] Clinical Trial
A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trialLetter Published on 2020-07-132022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 24 hour 48 hour Activation acute lung injury acute pneumonia acute respiratory distress syndrome Administered Adult age all-cause mortality Amendment antibodies antibody Antibody test anticipated antiviral therapy approval ARDS assessment assigned baseline Biomarker Blood cardiac disease Care change class Clinical improvement clinical study clinical trial complement Complement inhibitor component Computed tomography concealed Concentration conducted Confirmed Controlled coronary syndrome COVID-19 criteria current Day diagnosis of SARS-CoV-2 dialysis discharge dissemination dose Duration Efficacy element eligibility Endotracheal intubation EU Clinical Trial EudraCT evaluate the effect expected failure female patient Final fraction France Germany greater half-live hospital Hospitalization humanized Hypercoagulable state Immunoglobulin Infection Inflammatory inhibitor initiated intensive care Intubated intubation invasive Invasive mechanical ventilation investigator IVIG Japan Lung injury mechanical ventilation medication monoclonal multicenter Neisseria meningitidis Non-invasive number objective Open-label original outcome oxygen participant Patient patients randomized patients with COVID-19 Period peripheral capillary phase Placebo Pneumonia polymerase chain positive airway pressure presenting progression protocol randomised randomised controlled trial randomization randomization list Randomized randomized controlled study Randomly Ravulizumab receive recruitment registry Remdesivir renal respiratory respiratory distress Respiratory distress syndrome routine clinical care Safety screened Screening secondary Serious Adverse Events serum severe acute respiratory distress syndrome coronavirus 2 Severe acute respiratory syndrome severe COVID-19 severe pneumonia SOFA Spain SpO2 Sponsor stratified Study protocol supportive care survival The United States therapy time Treatment treatment-emergent adverse event Ultomiris United Kingdom ventricular Viral website with COVID-19 X-ray [DOI] 10.1186/s13063-020-04548-z PMC 바로가기 [Article Type] Letter
Identification of Falsified Chloroquine Tablets in Africa at the Time of the COVID-19 PandemicArticles Published on 2020-07-122022-10-28 Journal: The American Journal of Tropical Medicine and Hygi [Category] COVID-19, MERS, SARS, [키워드] absence Analysis Chloroquine conducted country COVID-19 detectable effective Germany Hydroxychloroquine identification Medicine Medicines Occurrence Paracetamol patients report required risk Tablet time Vaccine [DOI] 10.4269/ajtmh.20-0363 PMC 바로가기 [Article Type] Articles
ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trialLetter Published on 2020-07-022022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] active treatment phase Amiodarone anticipated Arm ARMS assessment baseline blinded Block randomisation block size Blood Group Breastfeeding Cambridge Care Chemoprophylaxis Chloroquine Chronic kidney disease ciprofloxacin clarithromycin clinical clinical testing Compliance Contact coronavirus disease COVID-19 COVID-19 case COVID-19 disease COVID-19 disease severity COVID-19 infection COVID-19 patients criteria current cyclosporin Daily Daily-dosing Date Day deficiency defined described determine diagnosed with COVID-19 Diagnosis digoxin disease dissemination dose dosed element enrolled enrolment epilepsy EU Clinical Trial EudraCT evaluated Factor File fluconazole Follow-up foundation frontline healthcare workers G6PD Genetic Glucose-6-phosphate halofantrine HCQ healthcare Healthcare workers heart failure hospital Hydroxychloroquine hypersensitivity reaction increase Infection Intervention investigator Laboratory Liver disease maintenance Matched mefloquine moxifloxacin National Health Service NHS number objective oral outcome participant Participants Patient patients with COVID-19 pharmacokinetic phase Placebo placebo tablet placebo-controlled trial porphyria positive COVID-19 positive individual Positive test Praziquantel predicted Prevent problem prochlorperazine protocol randomised randomised controlled trial recruited recruitment regimen Registered reported Research Retinal disease Sample size Secondary objective serology serum biomarker Standard statistical analysis status Stratification stratified Study protocol susceptibility symptoms onset syndrome table Tablet tablets time Treatment treatment period Trial Trust university Variation website Weekly Weekly-dosing work [DOI] 10.1186/s13063-020-04543-4 PMC 바로가기 [Article Type] Letter
Medical Education in Turkey in Time of COVID-19Editorial Published on 2020-07-012022-10-28 Journal: Balkan medical journal [Category] Coronavirus, MERS, SARS, [키워드] COVID-19 education time Turkey [DOI] 10.4274/balkanmedj.galenos.2020.2020.4.003 PMC 바로가기 [Article Type] Editorial